Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
Thomas G MartinMeletios- Athanasios DimopoulosJoseph R MikhaelKwee L YongMarcelo CapraThierry FaconRoman HájekIvan ŠpičkaRoss BakerKihyun KimGracia MartinezChang-Ki MinLudek PourXavier LeleuAlbert OrtiolYoungil KohKenshi SuzukiFrance CascaSandrine MacéMarie-Laure RissePhilippe MoreauPublished in: Blood cancer journal (2023)